US EditionStonegate Capital Partners Updates Coverage On Aemetis, Inc. (AMTX) Q1 2025
Summary by Kingston Whig-Standard
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Aemetis, Inc. Faces Revenue Decline Amid Strategic Growth Investments
Aemetis, Inc. (Nasdaq: AMTX) experienced a notable decline in total revenues during the first quarter of 2025, reporting $42.9M compared to $72.6M in the same period the previous year. This decrease is largely attributed to the timing shifts in receiving new government biodiesel contracts in India. Despite the revenue drop, the company’s net loss remained relatively stable at $24.5M, mirroring the $24.2M loss reported in Q1 2024. This stability …
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
